<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SNDX
Syndax
$
()


  • Syndax placed on 'Positive Catalyst Watch' at JPMorgan

    9/27/2024 - 07:03am
  • Syndax and Incyte announce publication of positive Niktimvo results in GVHD

    9/18/2024 - 17:22pm
  • Syndax price target raised by $4 at Citi, here's why

    8/16/2024 - 06:34am
  • Syndax price target raised by $4 at H.C. Wainwright, here's why

    8/15/2024 - 09:24am
  • Syndax price target raised by $1 at BofA, here's why

    8/15/2024 - 06:44am
  • Syndax price target raised by $1 at Barclays, here's why

    8/15/2024 - 05:44am
  • Closing Bell Movers: Cisco jumps over 5% after Q4 earnings beat

    8/14/2024 - 18:40pm
  • Incyte, Syndax announce FDA approval of Niktimvo

    8/14/2024 - 17:36pm
  • Syndax reports data from Phase 2 portion of AUGMENT-101 trial of revumenib

    8/12/2024 - 07:05am
  • Syndax reports Q2 EPS (80c), consensus (91c)

    8/1/2024 - 16:22pm
  • Syndax treatment of acute leukemias of ambiguous lineage granted orphan status

    8/1/2024 - 12:01pm
  • Syndax announces PDUFA action date extension for revumenib NDA

    7/29/2024 - 07:04am
  • Syndax participates in a conference call with JPMorgan

    7/15/2024 - 10:36am
  • Syndax granted orphan status for leukemia treatment

    7/11/2024 - 14:57pm
  • Syndax initiated with bullish view at Jefferies, here's why

    6/28/2024 - 05:22am
dynamic_feed Breaking News